What AI Medical does

AI Medical AG is a Swiss private medical device software company founded in 2021 and headquartered in Zollikon, near Zurich. It develops AI-powered automation and diagnostic software for neuroradiology, with its core product Jazz designed to assist radiologists in follow-up MRI assessments for multiple sclerosis and brain metastasis by automating lesion annotation, anatomical position detection, volumetric measurement, lesion counting, and report generation. Underlying technology combines deep learning and computer vision applied to DICOM MRI data, with capabilities for long-term volumetric lesion tracking across multiple follow-up scans and structured classification of lesion evolution (New, Expanding, Shrinking, Stable, Gone). The platform was validated on a 117-patient multi-center study (Switzerland, France, USA) demonstrating 63 new MS lesions and 95 slowly expanding lesions detected versus 24 and 0 respectively by standard clinical reads, with reports generated in under three minutes per case.

Jazz is regulated as a medical device and has received FDA 510(k) clearance (September 2023), CE marking under EU MDR (February 2023), ISO 13485 certification, and the Swiss Made Software label. A second product, Adage, is a free DICOM Anonymizer tool in beta. AI Medical's business model is enterprise, quote-based licensing or annual subscriptions to hospital radiology departments, sold via direct field engagement, demo requests, and presence at major radiology conferences (ECR, ESNR, ESTRO, ISRS). The company has a small core team (1-10 employees) led by founder and CEO Dr. Christian Federau, a practicing neuroradiologist, and is supported by Strategic and Medical Advisory Boards drawing from Stanford, ETH Zurich, Roche, Yale, Cambridge, Johns Hopkins, Toronto General Hospital, and Kyoto Prefectural University of Medicine. No external institutional funding rounds have been disclosed, suggesting an early-stage, largely bootstrapped commercial posture focused on regulatory clearance and clinical validation before scaling sales infrastructure.

Name

AI Medical

Legal name

AI Medical AG

Website

https://ai-medical.ch

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

AI Medical AG is a Swiss medical device software company that develops AI-powered automation software (Jazz) for neuroradiology, supporting hospital radiology departments with multiple sclerosis and brain metastasis follow-up MRI assessments.

Ownership category

akta.pro rank

Product category

Medical Imaging Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• Neuroradiology software
• Medical imaging AI
• Diagnostic radiology software
• DICOM anonymization
• Multiple sclerosis detection

Headquarters

HQ city

Zollikon

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Jazz Software License/Subscription: Jazz intelligent automation software sold to healthcare providers as a medical device software, likely on subscription or licensing basis given the enterprise sales motion and regulatory clearance requirements

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

AI Medical develops and sells Jazz, an FDA 510(k) cleared and CE-marked intelligent automation software for neuroradiology that assists radiologists in MRI follow-up assessments of multiple sclerosis and brain metastasis by automatically annotating lesions, measuring volumes, classifying lesion evolution, and producing standardized reports with quantitative findings. The company also offers Adage, a free beta DICOM header anonymization tool for macOS that supports secure medical imaging data handling.

Product overview

AI Medical offers a portfolio of two products for neuroradiology workflows. Jazz is the core intelligent automation software platform designed for MRI follow-up assessments, providing AI-powered lesion detection, tracking, and quantification for multiple sclerosis and brain metastasis. Adage is a complementary free DICOM anonymization utility that supports secure handling of medical imaging data headers. Together, these products address the complete imaging analysis workflow from data preparation through automated lesion assessment and reporting.

Differentiator

Problem solved

Functional benefit

Brands

• Jazz: Intelligent automation software for neuroradiology that automates lesion annotation, volume measurement, and counting for MRI follow-up assessments of multiple sclerosis and brain metastasis.
• Adage

Products and services

• Jazz Intelligent automation software for neuroradiology that assists radiologists and hospital radiology departments in MRI follow-up assessments of multiple sclerosis and brain metastasis. Jazz automates lesion annotation, detection, volumetric quantification, lesion evolution classification (New, Expanding, Shrinking, Stable, Gone), and auto-generates reports with numeration of findings and images, producing high-quality reports in under three minutes. Sold as an FDA 510(k) cleared and CE-marked medical device software on a subscription/license basis to healthcare providers.
• Adage (DICOM Anonymizer) Free beta DICOM Anonymizer tool for macOS that provides single-click safe anonymization of DICOM header information, with options to keep limited relevant information, hidden private tag exclusion, and unique anonymization number assignment. Distributed as a free downloadable beta supporting medical imaging data handling workflows.

Quantifiable outcome

• High-quality report generation in under 3 minutes per case
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• University Hospital ZurichcoreStrategic or Co-development PartnerClinical collaboration with University Hospital Zurich neuroradiology department. Dr. Nicolin Hainc, Assoc. Professor of Neuroradiology, serves on AI Medical's Medical Advisory Board and provided testimonial on Jazz software effectiveness.
• Stanford UniversitycoreStrategic or Co-development PartnerAcademic collaboration with Stanford University. Julian Maclaren, PhD, from Stanford and Google serves on AI Medical's Strategic Advisory Board.
• ETH ZurichcoreStrategic or Co-development PartnerAcademic partnership with ETH Zurich. Dr. Ender Konukoglu, Associate Professor of Biomedical Image Computing, serves on the Strategic Advisory Board.
• RocheminorStrategic or Co-development PartnerDamian Page, PhD, EMBA, from Roche serves on AI Medical's Strategic Advisory Board, bringing pharmaceutical and diagnostics expertise.
• Medical Advisory Board InstitutionscoreStrategic or Co-development PartnerMedical Advisory Board includes experts from Kyoto Prefectural University of Medicine, Toronto General Hospital, Yale University School of Medicine, Cambridge University Hospitals, and Johns Hopkins University School of Medicine, providing clinical and research guidance.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• RapidAI: RapidAI offers AI imaging software for stroke, aneurysm, and PE triage and quantification, including brain perfusion analysis. It competes with AI Medical in neuroradiology AI software for hospital radiology departments with FDA-cleared products.
• icometrix: icometrix is the most direct competitor, offering AI software (icobrain) for quantification of brain MRI in MS and other neurological conditions. Both companies target neuroradiology follow-up workflows for MS with volumetric lesion analysis, FDA-cleared and CE-marked SaMD.
• Qure.ai: Qure.ai develops AI solutions for medical imaging interpretation across head CT, chest X-ray, and musculoskeletal indications, with FDA and CE clearances. It is comparable to AI Medical as a deep-learning radiology AI vendor targeting hospital radiology workflows globally.
• Viz.ai: Viz.ai is a leading radiology AI platform with FDA-cleared software for stroke and other neurovascular conditions, sold to hospital radiology and stroke teams. Overlaps with AI Medical on AI-powered neuro imaging and hospital enterprise sales motion.
• Cortechs.ai: Cortechs.ai develops AI-powered quantitative imaging tools for brain MRI, including NeuroQuant for brain volumetrics and lesion segmentation. It is a direct competitor in AI brain MRI analysis for neuroradiology applications.

Broad incumbents

• Aidoc: Aidoc is a broad radiology AI incumbent covering multiple indications (stroke, PE, trauma, etc.) with FDA-cleared triage and worklist products sold to hospital radiology departments. It competes with AI Medical for the same hospital procurement budgets and IT integration points.
• DeepHealth (RadNet): DeepHealth, a RadNet subsidiary, develops AI-powered medical imaging solutions across multiple modalities and clinical indications. It is a broader incumbent in radiology AI that competes for hospital and clinic AI deployment budgets.

Emerging players

• Arterys: Arterys (now part of Tempus) provides cloud-native AI medical imaging platforms for cardiac, lung, and other radiology applications. It is comparable as an AI imaging SaaS vendor selling to hospital radiology departments with regulatory clearances.
• Subtle Medical: Subtle Medical offers AI-driven image enhancement software for MRI and PET, improving scan quality and reducing acquisition times. It is an adjacent AI imaging vendor targeting the same hospital radiology customers as AI Medical.
• Blackford Analysis: Blackford Analysis provides an AI platform that curates and distributes third-party radiology AI algorithms to hospitals and imaging providers. Comparable to AI Medical as a radiology AI distribution channel and a potential partner or competitor for hospital contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/AI_MedicalAG
• LinkedInlinkedin.com/company/ai-medical-ag
• Instagraminstagram.com/ai_medicalag

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AI Medical